Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01988532 · ClinicalTrials.gov registry record
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 381
- Enrollment target
NCT01988532: Completed study, sponsored by Novo Nordisk A/S.
NCT01988532 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 381 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01988532 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 381 participants
- Enrollment target
Study Summary
This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-10 |
What the finished NCT01988532 record still lists
NCT01988532 is an observational study that tracks outcomes without assigning an intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT01988532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01988532 about?
NCT01988532 is a clinical study titled "Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia". This study is conducted in the United States of America (USA). The aim of the study is to assess the impact of pain on functional impairment and quality of life in adult persons with hemophilia (PWH) with and without inhibitors with joint bleeding.
What is the current status of trial NCT01988532?
This trial is currently completed. The enrollment target is 381 participants. The study started on 2013-10. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01988532?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT01988532?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia